Product Information
CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0880 per EA under NDC 00143992701. Its NADAC has been published 649 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143992701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076558On Market Since
6/9/2004
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 649 times since Nov 28, 2013, and over the history we have for it it has declined 30.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0880 per EA |
|---|---|
| All-time high | $0.1749 (Jun 10, 2015) |
| All-time low | $0.0811 (Nov 20, 2024) |
| 52-week high | $0.0917 |
| 52-week low | $0.0871 |
| Median price | $0.0997 |
| Average price | $0.1094 |
| Largest weekly change | -21.4% (Apr 17, 2024) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0880 per EA (NDC 00143992701), effective Apr 29, 2026.
How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 30.7%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?
Since Nov 28, 2013, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0811 (Nov 20, 2024) to a high of $0.1749 (Jun 10, 2015), with a median of $0.0997 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CIPROFLOXACIN HCL 250 MG TAB, but none are currently priced below it.
Who manufactures CIPROFLOXACIN HCL 250 MG TAB?
CIPROFLOXACIN HCL 250 MG TAB (NDC 00143992701) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification